General MedicationsINJECTIONStandard
LOQTORZI
TORIPALIMAB-TPZI
Standard Dose
240MG/6ML(40MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LOQTORZI is listed in Drugs@FDA under application 761240 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TORIPALIMAB-TPZI Form and strength INJECTABLE;INJECTION - 240MG/6ML(40MG/ML) Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2024-10-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview LOQTORZI is listed in Drugs@FDA under application 761240 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TORIPALIMAB-TPZI Form and strength INJECTABLE;INJECTION - 240MG/6ML(40MG/ML) Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2024-10-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.